
Search SNP
Search Gene
Search CNV
Search Haplotype
Search Other Variant
Search Region
Search Pathway
Search Study
BD & MDD shared genes
Total unique gene count: 236
Note: For BD-MDD shared genes, genes from cross-disorder studies about BD-MDD or BD-SZ-MDD were considered from cross-disorder studies, genes from intersection analysis of BDgene and MK4MDD were considered from candidate gene intersection analysis. Some repeated genes may be both included in cross-disorder studies and the result of candidate gene intersection analysis.
Approved Symbol | Approved Name | Location | No. of Studies for BD (Positive/Negative/Trend) | Overlap with SZ | Overlap with MDD | ![]() |
---|---|---|---|---|---|---|
SLC6A4 | solute carrier family 6 (neurotransmitter transporter), member 4 | 17q11.2 | 44(18/26/0) | YES | YES | |
BDNF | brain-derived neurotrophic factor | 11p14.1 | 37(24/12/1) | YES | YES | |
COMT | catechol-O-methyltransferase | 22q11.21 | 28(14/14/0) | YES | YES | |
DRD2 | dopamine receptor D2 | 11q22-q23 | 28(8/20/0) | YES | YES | |
HTR2A | 5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled | 13q14-q21 | 22(7/15/0) | YES | YES | |
DAOA | D-amino acid oxidase activator | 13q33.2 | 21(13/7/1) | YES | YES | |
MAOA | monoamine oxidase A | Xp11.4-p11.3 | 21(10/11/0) | YES | YES | |
CACNA1C | calcium channel, voltage-dependent, L type, alpha 1C subunit | 12p13.3 | 20(17/3/0) | YES | YES | |
DRD3 | dopamine receptor D3 | 3q13.3 | 19(4/15/0) | YES | YES | |
DISC1 | disrupted in schizophrenia 1 | 1q42.1 | 18(10/7/1) | YES | YES | |
ANK3 | ankyrin 3, node of Ranvier (ankyrin G) | 10q21 | 17(13/3/1) | YES | YES | |
TH | tyrosine hydroxylase | 11p15.5 | 16(4/12/0) | YES | YES | |
MTHFR | methylenetetrahydrofolate reductase (NAD(P)H) | 1p36.3 | 16(10/6/0) | YES | YES | |
TPH1 | tryptophan hydroxylase 1 | 11p15.3-p14 | 14(5/9/0) | YES | YES | |
TPH2 | tryptophan hydroxylase 2 | 12q15 | 13(10/3/0) | YES | YES | |
DRD4 | dopamine receptor D4 | 11p15.5 | 13(1/12/0) | YES | YES | |
CLOCK | clock circadian regulator | 4q12 | 12(5/7/0) | YES | YES | |
SLC6A3 | solute carrier family 6 (neurotransmitter transporter), member 3 | 5p15.3 | 11(5/6/0) | YES | YES | |
P2RX7 | purinergic receptor P2X, ligand gated ion channel, 7 | 12q24 | 9(2/7/0) | YES | YES | |
GSK3B | glycogen synthase kinase 3 beta | 3q13.3 | 8(0/8/0) | YES | YES | |
DTNBP1 | dystrobrevin binding protein 1 | 6p22.3 | 8(4/3/1) | YES | YES | |
NOS1 | nitric oxide synthase 1 (neuronal) | 12q24.22 | 8(2/5/1) | YES | YES | |
WFS1 | Wolfram syndrome 1 (wolframin) | 4p16.1 | 7(1/6/0) | YES | YES | |
PER2 | period circadian clock 2 | 2q37.3 | 7(1/6/0) | YES | YES | |
GRM3 | glutamate receptor, metabotropic 3 | 7q21.1-q21.2 | 7(3/4/0) | YES | YES | |
PER3 | period circadian clock 3 | 1p36.23 | 7(3/4/0) | YES | YES | |
ARNTL | aryl hydrocarbon receptor nuclear translocator-like | 11p15 | 7(5/2/0) | YES | YES | |
HTR2C | 5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled | Xq23 | 7(4/3/0) | YES | YES | |
SYNE1 | spectrin repeat containing, nuclear envelope 1 | 6q25.2 | 6(3/2/1) | YES | YES | |
NR1D1 | nuclear receptor subfamily 1, group D, member 1 | 17q11.2 | 6(2/4/0) | YES | YES | |
TENM4 | teneurin transmembrane protein 4 | 11q13 | 6(4/2/0) | YES | YES | |
GABRA5 | gamma-aminobutyric acid (GABA) A receptor, alpha 5 | 15q12 | 6(6/0/0) | YES | YES | |
DGKH | diacylglycerol kinase, eta | 13q13.3 | 6(3/3/0) | YES | YES | |
TAAR6 | trace amine associated receptor 6 | 6q23.1 | 5(4/1/0) | YES | YES | |
NPAS2 | neuronal PAS domain protein 2 | 2q11.2 | 5(3/2/0) | YES | YES | |
CSNK1E | casein kinase 1, epsilon | 22q13.1 | 5(1/3/1) | YES | YES | |
CNR1 | cannabinoid receptor 1 (brain) | 6q14-q15 | 5(0/5/0) | YES | YES | |
PBRM1 | polybromo 1 | 3p21 | 5(4/0/1) | YES | YES | |
DDC | dopa decarboxylase (aromatic L-amino acid decarboxylase) | 7p12.1 | 5(2/3/0) | YES | YES | |
FKBP5 | FK506 binding protein 5 | 6p21.31 | 5(1/4/0) | YES | YES | |
ACE | angiotensin I converting enzyme | 17q23.3 | 5(2/3/0) | YES | YES | |
CRY2 | cryptochrome circadian clock 2 | 11p11.2 | 5(3/2/0) | YES | YES | |
PER1 | period circadian clock 1 | 17p13.1 | 5(2/3/0) | YES | YES | |
DUSP6 | dual specificity phosphatase 6 | 12q22-q23 | 5(3/2/0) | YES | YES | |
TSNAX | translin-associated factor X | 1q42.2 | 4(3/1/0) | YES | YES | |
CSNK1D | casein kinase 1, delta | 17q25 | 4(2/2/0) | YES | YES | |
CRHR1 | corticotropin releasing hormone receptor 1 | 17q21.31 | 4(2/2/0) | NO | YES | |
AVPR1B | arginine vasopressin receptor 1B | 1q32 | 4(3/1/0) | NO | YES | |
RORB | RAR-related orphan receptor B | 9q22 | 4(3/1/0) | YES | YES | |
MAOB | monoamine oxidase B | Xp11.4-p11.3 | 4(2/2/0) | YES | YES | |
TSPO | translocator protein (18kDa) | 22q13.3 | 3(1/2/0) | YES | YES | |
BHLHE41 | basic helix-loop-helix family, member e41 | 12p12.1 | 3(2/1/0) | YES | YES | |
CACNB2 | calcium channel, voltage-dependent, beta 2 subunit | 10p12 | 3(2/1/0) | YES | YES | |
TIMELESS | timeless circadian clock | 12q13.3 | 3(0/3/0) | YES | YES | |
HTR6 | 5-hydroxytryptamine (serotonin) receptor 6, G protein-coupled | 1p36-p35 | 3(1/2/0) | YES | YES | |
DBP | D site of albumin promoter (albumin D-box) binding protein | 19q13.33 | 3(0/3/0) | YES | YES | |
HTR1A | 5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled | 5q11.2-q13 | 3(2/1/0) | YES | YES | |
GPR50 | G protein-coupled receptor 50 | Xq28 | 3(2/1/0) | YES | YES | |
CRHR2 | corticotropin releasing hormone receptor 2 | 7p14.3 | 3(2/1/0) | NO | YES | |
EGR3 | early growth response 3 | 8p23-p21 | 3(2/1/0) | YES | YES | |
CCL2 | chemokine (C-C motif) ligand 2 | 17q11.2-q21.1 | 3(1/2/0) | YES | YES | |
ADCYAP1 | adenylate cyclase activating polypeptide 1 (pituitary) | 18p11 | 3(1/2/0) | YES | YES | |
NTRK2 | neurotrophic tyrosine kinase, receptor, type 2 | 9q22.1 | 3(1/1/1) | YES | YES | |
ARNTL2 | aryl hydrocarbon receptor nuclear translocator-like 2 | 12p12.2-p11.2 | 3(1/2/0) | YES | YES | |
ITIH3 | inter-alpha-trypsin inhibitor heavy chain 3 | 3p21.1 | 3(3/0/0) | YES | YES | |
NCAM1 | neural cell adhesion molecule 1 | 11q23.2 | 3(2/1/0) | YES | YES | |
DBH | dopamine beta-hydroxylase (dopamine beta-monooxygenase) | 9q34 | 3(1/2/0) | YES | YES | |
SP8 | Sp8 transcription factor | 7p21.2 | 3(2/0/1) | YES | YES | |
RORA | RAR-related orphan receptor A | 15q21-q22 | 3(2/1/0) | NO | YES | |
GNL3 | guanine nucleotide binding protein-like 3 (nucleolar) | 3p21.1 | 2(2/0/0) | YES | YES | |
GABRA1 | gamma-aminobutyric acid (GABA) A receptor, alpha 1 | 5q34 | 2(1/1/0) | YES | YES | |
TIPIN | TIMELESS interacting protein | 15q22.31 | 2(0/2/0) | YES | YES | |
SOD2 | superoxide dismutase 2, mitochondrial | 6q25 | 2(1/1/0) | YES | YES | |
HSPA1A | heat shock 70kDa protein 1A | 6p21.3 | 2(2/0/0) | YES | YES | |
CSNK2A1 | casein kinase 2, alpha 1 polypeptide | 20p13 | 2(0/2/0) | YES | YES | |
AANAT | aralkylamine N-acetyltransferase | 17q25.1 | 2(0/2/0) | YES | YES | |
CCK | cholecystokinin | 3p22.1 | 2(0/1/1) | YES | YES | |
FOXP2 | forkhead box P2 | 7q31 | 2(0/2/0) | YES | YES | |
ABCA13 | ATP-binding cassette, sub-family A (ABC1), member 13 | 7p12.3 | 2(2/0/0) | YES | YES | |
HTR4 | 5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled | 5q31-q33 | 2(1/1/0) | YES | YES | |
GNB3 | guanine nucleotide binding protein (G protein), beta polypeptide 3 | 12p13 | 2(1/1/0) | YES | YES | |
ERBB4 | erb-b2 receptor tyrosine kinase 4 | 2q33.3-q34 | 2(1/1/0) | YES | YES | |
CRY1 | cryptochrome circadian clock 1 | 12q23-q24.1 | 2(1/1/0) | NO | YES | |
BCL2 | B-cell CLL/lymphoma 2 | 18q21.3 | 2(0/2/0) | NO | YES | |
NOS3 | nitric oxide synthase 3 (endothelial cell) | 7q36 | 2(1/1/0) | YES | YES | |
FAAH | fatty acid amide hydrolase | 1p35-p34 | 2(0/2/0) | YES | YES | |
GCH1 | GTP cyclohydrolase 1 | 14q22.1-q22.2 | 2(1/1/0) | NO | YES | |
MYO18B | myosin XVIIIB | 22q12.1 | 2(0/2/0) | YES | YES | |
ADCY9 | adenylate cyclase 9 | 16p13.3 | 2(1/1/0) | NO | YES | |
HTR5A | 5-hydroxytryptamine (serotonin) receptor 5A, G protein-coupled | 7q36.1 | 2(1/1/0) | YES | YES | |
BCR | breakpoint cluster region | 22q11 | 2(1/1/0) | NO | YES | |
NPAS3 | neuronal PAS domain protein 3 | 14q13.1 | 2(1/1/0) | YES | YES | |
CTLA4 | cytotoxic T-lymphocyte-associated protein 4 | 2q33 | 2(1/1/0) | YES | YES | |
CREB1 | cAMP responsive element binding protein 1 | 2q34 | 2(1/1/0) | NO | YES | |
KAT5 | K(lysine) acetyltransferase 5 | 11q13 | 2(0/2/0) | NO | YES | |
CSF2RB | colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) | 22q12.3 | 2(1/1/0) | YES | YES | |
NFIL3 | nuclear factor, interleukin 3 regulated | 9q22 | 2(0/2/0) | YES | YES | |
FGFR2 | fibroblast growth factor receptor 2 | 10q25.3-q26 | 2(1/1/0) | YES | YES | |
DRD5 | dopamine receptor D5 | 4p16.1 | 2(0/2/0) | YES | YES | |
NT5C2 | 5'-nucleotidase, cytosolic II | 10q24.32 | 2(2/0/0) | YES | YES | |
YWHAE | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon | 17p13.3 | 1(0/1/0) | YES | YES | |
VIP | vasoactive intestinal peptide | 6q24-q27 | 1(1/0/0) | NO | YES | |
NQO1 | NAD(P)H dehydrogenase, quinone 1 | 16q12-q22 | 1(0/1/0) | YES | YES | |
CREM | cAMP responsive element modulator | 10p12.1-p11.1 | 1(0/1/0) | NO | YES | |
CRIM1 | cysteine rich transmembrane BMP regulator 1 (chordin-like) | 2p21 | 1(0/1/0) | YES | YES | |
IFT88 | intraflagellar transport 88 | 13q12.1 | 1(0/1/0) | YES | YES | |
BCL9 | B-cell CLL/lymphoma 9 | 1q21 | 1(1/0/0) | YES | YES | |
GRM2 | glutamate receptor, metabotropic 2 | 3p21.2 | 1(0/1/0) | YES | YES | |
TXNL1 | thioredoxin-like 1 | 18q21.31 | 1(0/0/1) | YES | YES | |
NR4A2 | nuclear receptor subfamily 4, group A, member 2 | 2q22-q23 | 1(0/1/0) | YES | YES | |
GRIK3 | glutamate receptor, ionotropic, kainate 3 | 1p34.3 | 1(1/0/0) | YES | YES | |
CCDC102B | coiled-coil domain containing 102B | 18q22.1 | 1(0/1/0) | YES | YES | |
FAM20B | family with sequence similarity 20, member B | 1q25.2 | 1(0/1/0) | YES | YES | |
MDGA1 | MAM domain containing glycosylphosphatidylinositol anchor 1 | 6p21 | 1(1/0/0) | YES | YES | |
PAWR | PRKC, apoptosis, WT1, regulator | 12q21.2 | 1(0/1/0) | YES | YES | |
CREBBP | CREB binding protein | 16p13.3 | 1(0/1/0) | NO | YES | |
AS3MT | arsenite methyltransferase | 10q24.33 | 1(1/0/0) | YES | YES | |
GNB1L | guanine nucleotide binding protein (G protein), beta polypeptide 1-like | 22q11.2 | 1(1/0/0) | YES | YES | |
ACTR3B | ARP3 actin-related protein 3 homolog B (yeast) | 7q36.1 | 1(0/0/1) | YES | YES | |
KLK8 | kallikrein-related peptidase 8 | 19q13 | 1(1/0/0) | YES | YES | |
CTNND2 | catenin (cadherin-associated protein), delta 2 | 5p15.2 | 1(0/1/0) | YES | YES | |
ANXA1 | annexin A1 | 9q21.13 | 1(0/0/1) | YES | YES | |
IL6 | interleukin 6 | 7p21-p15 | 1(0/1/0) | YES | YES | |
VIPR2 | vasoactive intestinal peptide receptor 2 | 7q36.3 | 1(1/0/0) | YES | YES | |
SAMSN1 | SAM domain, SH3 domain and nuclear localization signals 1 | 21q11 | 1(0/1/0) | YES | YES | |
CCDC68 | coiled-coil domain containing 68 | 18q21 | 1(1/0/0) | YES | YES | |
SEL1L2 | sel-1 suppressor of lin-12-like 2 (C. elegans) | 20p12.1 | 1(0/1/0) | YES | YES | |
ADM | adrenomedullin | 11p15.4 | 1(1/0/0) | YES | YES | |
EIF2AK4 | eukaryotic translation initiation factor 2 alpha kinase 4 | 15q13.3 | 1(0/1/0) | YES | YES | |
FZD3 | frizzled class receptor 3 | 8p21 | 1(0/1/0) | YES | YES | |
OXTR | oxytocin receptor | 3p25 | 1(0/1/0) | YES | YES | |
CHCHD3 | coiled-coil-helix-coiled-coil-helix domain containing 3 | 7q33 | 1(0/1/0) | YES | YES | |
PROK2 | prokineticin 2 | 3p21.1 | 1(0/1/0) | NO | YES | |
ANO2 | anoctamin 2, calcium activated chloride channel | 12p13.3 | 1(0/1/0) | YES | YES | |
RBMS3 | RNA binding motif, single stranded interacting protein 3 | 3p24-p23 | 1(0/1/0) | YES | YES | |
PPP2R2D | protein phosphatase 2, regulatory subunit B, delta | 10q26.3 | 1(0/0/1) | YES | YES | |
DHX15 | DEAH (Asp-Glu-Ala-His) box helicase 15 | 4p15.3 | 1(1/0/0) | YES | YES | |
PROKR2 | prokineticin receptor 2 | 20p12.3 | 1(1/0/0) | NO | YES | |
OPTN | optineurin | 10p14 | 1(0/0/1) | YES | YES |
Approved Symbol | Approved Name | Location | No. of Studies for BD (Positive/Negative/Trend) | Overlap with SZ | Overlap with MDD | ![]() |
---|---|---|---|---|---|---|
SLC6A4 | solute carrier family 6 (neurotransmitter transporter), member 4 | 17q11.2 | 44(18/26/0) | YES | YES | |
BDNF | brain-derived neurotrophic factor | 11p14.1 | 37(24/12/1) | YES | YES | |
COMT | catechol-O-methyltransferase | 22q11.21 | 28(14/14/0) | YES | YES | |
DRD2 | dopamine receptor D2 | 11q22-q23 | 28(8/20/0) | YES | YES | |
HTR2A | 5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled | 13q14-q21 | 22(7/15/0) | YES | YES | |
DAOA | D-amino acid oxidase activator | 13q33.2 | 21(13/7/1) | YES | YES | |
MAOA | monoamine oxidase A | Xp11.4-p11.3 | 21(10/11/0) | YES | YES | |
DISC1 | disrupted in schizophrenia 1 | 1q42.1 | 18(10/7/1) | YES | YES | |
MTHFR | methylenetetrahydrofolate reductase (NAD(P)H) | 1p36.3 | 16(10/6/0) | YES | YES | |
TPH1 | tryptophan hydroxylase 1 | 11p15.3-p14 | 14(5/9/0) | YES | YES | |
TPH2 | tryptophan hydroxylase 2 | 12q15 | 13(10/3/0) | YES | YES | |
DRD4 | dopamine receptor D4 | 11p15.5 | 13(1/12/0) | YES | YES | |
CLOCK | clock circadian regulator | 4q12 | 12(5/7/0) | YES | YES | |
SLC6A3 | solute carrier family 6 (neurotransmitter transporter), member 3 | 5p15.3 | 11(5/6/0) | YES | YES | |
P2RX7 | purinergic receptor P2X, ligand gated ion channel, 7 | 12q24 | 9(2/7/0) | YES | YES | |
GSK3B | glycogen synthase kinase 3 beta | 3q13.3 | 8(0/8/0) | YES | YES | |
DTNBP1 | dystrobrevin binding protein 1 | 6p22.3 | 8(4/3/1) | YES | YES | |
NOS1 | nitric oxide synthase 1 (neuronal) | 12q24.22 | 8(2/5/1) | YES | YES | |
WFS1 | Wolfram syndrome 1 (wolframin) | 4p16.1 | 7(1/6/0) | YES | YES | |
GRM3 | glutamate receptor, metabotropic 3 | 7q21.1-q21.2 | 7(3/4/0) | YES | YES | |
HTR2C | 5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled | Xq23 | 7(4/3/0) | YES | YES | |
SYNE1 | spectrin repeat containing, nuclear envelope 1 | 6q25.2 | 6(3/2/1) | YES | YES | |
NR1D1 | nuclear receptor subfamily 1, group D, member 1 | 17q11.2 | 6(2/4/0) | YES | YES | |
GABRA5 | gamma-aminobutyric acid (GABA) A receptor, alpha 5 | 15q12 | 6(6/0/0) | YES | YES | |
DGKH | diacylglycerol kinase, eta | 13q13.3 | 6(3/3/0) | YES | YES | |
NPAS2 | neuronal PAS domain protein 2 | 2q11.2 | 5(3/2/0) | YES | YES | |
CNR1 | cannabinoid receptor 1 (brain) | 6q14-q15 | 5(0/5/0) | YES | YES | |
FKBP5 | FK506 binding protein 5 | 6p21.31 | 5(1/4/0) | YES | YES | |
ACE | angiotensin I converting enzyme | 17q23.3 | 5(2/3/0) | YES | YES | |
TSNAX | translin-associated factor X | 1q42.2 | 4(3/1/0) | YES | YES | |
CRHR1 | corticotropin releasing hormone receptor 1 | 17q21.31 | 4(2/2/0) | NO | YES | |
AVPR1B | arginine vasopressin receptor 1B | 1q32 | 4(3/1/0) | NO | YES | |
HTR1A | 5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled | 5q11.2-q13 | 3(2/1/0) | YES | YES | |
GPR50 | G protein-coupled receptor 50 | Xq28 | 3(2/1/0) | YES | YES | |
CRHR2 | corticotropin releasing hormone receptor 2 | 7p14.3 | 3(2/1/0) | NO | YES | |
EGR3 | early growth response 3 | 8p23-p21 | 3(2/1/0) | YES | YES | |
CCL2 | chemokine (C-C motif) ligand 2 | 17q11.2-q21.1 | 3(1/2/0) | YES | YES | |
ADCYAP1 | adenylate cyclase activating polypeptide 1 (pituitary) | 18p11 | 3(1/2/0) | YES | YES | |
NTRK2 | neurotrophic tyrosine kinase, receptor, type 2 | 9q22.1 | 3(1/1/1) | YES | YES | |
NCAM1 | neural cell adhesion molecule 1 | 11q23.2 | 3(2/1/0) | YES | YES | |
GABRA1 | gamma-aminobutyric acid (GABA) A receptor, alpha 1 | 5q34 | 2(1/1/0) | YES | YES | |
SOD2 | superoxide dismutase 2, mitochondrial | 6q25 | 2(1/1/0) | YES | YES | |
AANAT | aralkylamine N-acetyltransferase | 17q25.1 | 2(0/2/0) | YES | YES | |
HTR4 | 5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled | 5q31-q33 | 2(1/1/0) | YES | YES | |
GNB3 | guanine nucleotide binding protein (G protein), beta polypeptide 3 | 12p13 | 2(1/1/0) | YES | YES | |
CRY1 | cryptochrome circadian clock 1 | 12q23-q24.1 | 2(1/1/0) | NO | YES | |
HTR5A | 5-hydroxytryptamine (serotonin) receptor 5A, G protein-coupled | 7q36.1 | 2(1/1/0) | YES | YES | |
NPAS3 | neuronal PAS domain protein 3 | 14q13.1 | 2(1/1/0) | YES | YES | |
CTLA4 | cytotoxic T-lymphocyte-associated protein 4 | 2q33 | 2(1/1/0) | YES | YES | |
CREB1 | cAMP responsive element binding protein 1 | 2q34 | 2(1/1/0) | NO | YES | |
KAT5 | K(lysine) acetyltransferase 5 | 11q13 | 2(0/2/0) | NO | YES | |
CSF2RB | colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) | 22q12.3 | 2(1/1/0) | YES | YES | |
FGFR2 | fibroblast growth factor receptor 2 | 10q25.3-q26 | 2(1/1/0) | YES | YES | |
YWHAE | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon | 17p13.3 | 1(0/1/0) | YES | YES | |
NQO1 | NAD(P)H dehydrogenase, quinone 1 | 16q12-q22 | 1(0/1/0) | YES | YES | |
CREM | cAMP responsive element modulator | 10p12.1-p11.1 | 1(0/1/0) | NO | YES | |
NR4A2 | nuclear receptor subfamily 4, group A, member 2 | 2q22-q23 | 1(0/1/0) | YES | YES | |
GRIK3 | glutamate receptor, ionotropic, kainate 3 | 1p34.3 | 1(1/0/0) | YES | YES | |
PAWR | PRKC, apoptosis, WT1, regulator | 12q21.2 | 1(0/1/0) | YES | YES | |
CREBBP | CREB binding protein | 16p13.3 | 1(0/1/0) | NO | YES | |
IL6 | interleukin 6 | 7p21-p15 | 1(0/1/0) | YES | YES | |
SEL1L2 | sel-1 suppressor of lin-12-like 2 (C. elegans) | 20p12.1 | 1(0/1/0) | YES | YES | |
ADM | adrenomedullin | 11p15.4 | 1(1/0/0) | YES | YES | |
PROK2 | prokineticin 2 | 3p21.1 | 1(0/1/0) | NO | YES | |
PROKR2 | prokineticin receptor 2 | 20p12.3 | 1(1/0/0) | NO | YES |